✦ LIBER ✦

2139 Chemotherapy followed by a combination of daily irradiation and carboplatine (CBDCA) in stage IIIB non small cell lung cancer (NSCLC): First interim analysis of a phase II trial

✍ Scribed by E. Bardet; J.Y. Douillard; A. Rivière; E. Quoix; D. Spaeth; A. Ducolone; B. Coudert; J.L. Lagrange; P. Chomy; C. Tuchais; B. Pellae-Cosset; M. Henry-Amar

Book ID: 108437035
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 234 KB
Volume: 36
Category: Article
ISSN: 0360-3016
DOI: 10.1016/s0360-3016(97)85714-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II Trial of Docetaxel and Carbop

Phase I/II Trial of Docetaxel and Carboplatin as a First-Line Therapy in Patients with Stage IV Non-Small-Cell Lung Cancer

✍ Kensuke Kataoka; Ryujiro Suzuki; Hiroyuki Taniguchi; Yasunobu Noda; Joe Shindoh; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 82 KB

Gemcitabine and vinorelbine followed by

Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy

✍ Manuel Cobo Dols; Esther Villar Chamorro; Inmaculada Alés Díaz; Silvia Gil Calle 📂 Article 📅 2006 🏛 Springer Milan 🌐 Spanish ⚖ 835 KB

A phase I/randomized phase II, non-compa

A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC)

✍ Roger B. Cohen; Corey J. Langer; George Rajan Simon; Peter David Eisenberg; John 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 387 KB

A randomised phase II trial of docetaxel

A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb–IV non-small-cell lung cancer who failed first-line treatment

✍ Wachters, F M; Groen, H J M; Biesma, B; Schramel, F M N H; Postmus, P E; Stigt, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB

Docetaxel/gemcitabine or cisplatin/gemci

Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial

✍ D. Binder; H. Schweisfurth; C. Grah; C. Schäper; B. Temmesfeld-Wollbrück; G. Sie 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 340 KB

Multicenter phase II trial of accelerate

Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease)

✍ Phernambucq, E C J; Biesma, B; Smit, E F; Paul, M A; Tol, A vd; Schramel, F M; B 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 93 KB